Catalyst Wire Dossier Catalyst Wire Dossier

amlodipine/valsartan 5/40

amlodipine/valsartan · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for amlodipine/valsartan 5/40, covering 2011-06-06 to 2011-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension [Phase 3]

See pricing